Cite
Terakawa T, Katsuta E, Yan L, et al. High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget. 2018;9(18):14207-14218doi: 10.18632/oncotarget.24453.
Terakawa, T., Katsuta, E., Yan, L., Turaga, N., McDonald, K. A., Fujisawa, M., Guru, K. A., & Takabe, K. (2018). High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget, 9(18), 14207-14218. https://doi.org/10.18632/oncotarget.24453
Terakawa, Tomoaki, et al. "High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy." Oncotarget vol. 9,18 (2018): 14207-14218. doi: https://doi.org/10.18632/oncotarget.24453
Terakawa T, Katsuta E, Yan L, Turaga N, McDonald KA, Fujisawa M, Guru KA, Takabe K. High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget. 2018 Feb 08;9(18):14207-14218. doi: 10.18632/oncotarget.24453. eCollection 2018 Mar 06. PMID: 29581838; PMCID: PMC5865664.
Copy
Download .nbib